Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)
about
Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survivalGABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma.Prognostic significance of ZEB1 and ZEB2 in digestive cancers: a cohort-based analysis and secondary analysis.Prognostic significance of E-cadherin expression in hepatocellular carcinoma: a meta-analysis.Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivoZEB1 expression in endometrial biopsy predicts lymph node metastases in patient with endometrial cancer.microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells.Pygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by decreasing E-cadherin expression.MicroRNA-145 inhibits human papillary cancer TPC1 cell proliferation by targeting DUSP6Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgeryNestin overexpression in hepatocellular carcinoma associates with epithelial-mesenchymal transition and chemoresistance.Investigating the Molecular Basis of PPCD3: Characterization of ZEB1 Regulation of COL4A3 Expression.Significance of the hedgehog pathway-associated proteins Gli-1 and Gli-2 and the epithelial-mesenchymal transition-associated proteins Twist and E-cadherin in hepatocellular carcinoma.Down-regulation of β-arrestin2 promotes tumour invasion and indicates poor prognosis of hepatocellular carcinomaRARγ-induced E-cadherin downregulation promotes hepatocellular carcinoma invasion and metastasis.MYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transitionTranscription regulation of E-cadherin by zinc finger E-box binding homeobox proteins in solid tumorsIdentification of upstream transcription factors (TFs) for expression signature genes in breast cancer.A kinetic model of multiple phenotypic states for breast cancer cells.Comprehensive characterization of the patient-derived xenograft and the paralleled primary hepatocellular carcinoma cell line.MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.In vivo and in vitro effect of hepatocarcinoma lymph node metastasis by upregulation of Annexin A7 and relevant mechanisms.Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells.Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.Hepatitis C virus core protein interacts with Snail and histone deacetylases to promote the metastasis of hepatocellular carcinoma.Impact of positive ZEB1 expression in patients with epithelial ovarian carcinoma as an oncologic outcome-predicting indicator.Overexpression of EMT-inducing transcription factors as a potential poor prognostic factor for hepatocellular carcinoma in Asian populations: A meta-analysis.Changes in microRNA expression during disease progression in patients with chronic viral hepatitis.Expression of E-cadherin in oral lichen planus.Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells.Snail collaborates with EGR-1 and SP-1 to directly activate transcription of MMP 9 and ZEB1.Clinical significance of CD13 and epithelial mesenchymal transition (EMT) markers in hepatocellular carcinoma.Evidence for a role of E-cadherin in suppressing liver carcinogenesis in mice and men.Nuclear, cytoplasmic, and stromal expression of ZEB1 in squamous and small cell carcinoma of the esophagus.
P2860
Q26853543-C23EA190-CAFA-4A8C-B244-44B0B6990BF4Q33733761-73E8EF30-5C7F-49A7-865E-443622E8D248Q33761782-8F41EA54-A06A-40B2-A805-01A5E43B1E85Q34004801-AB78FD20-1F4E-46E3-80F7-9B9508576B8CQ34402163-5ADC3B15-DEB8-4D55-A72F-797EFCA39563Q34722585-9296CA62-91DF-47DC-B79A-363B0C06E310Q35450947-0C7BD168-4B74-4A18-9139-688471A77871Q35793718-F5455C05-52E9-4ACD-BF18-E466C75FD083Q35959029-410C6B42-B2FA-4F0D-A434-B90B3DEF75F6Q36734211-87F7C97F-982F-441B-B688-C62795B85AFCQ37093999-F7966051-242D-45D7-8A6B-78F531A334D9Q37189220-A9E7ABFA-3839-4FEE-B69D-5BC6F10A181DQ37204746-40D70436-8536-4D24-A453-39A0FA803018Q37349092-6D3AE4F5-0D09-413A-9DA2-A16AE83FE006Q37349514-096045E7-7BB2-4203-A4E6-9782F99BBBB2Q37699248-74B6D7FA-B852-4C67-8A91-FA68D1B7905DQ38246793-05A2CE01-EF84-4647-9069-5CC7112BE5A9Q38440765-5051B5F2-4EC6-461F-A5FF-FB6107CAD726Q38693858-2F141699-4AF4-4891-A359-C307E940A489Q38765553-AD7C4708-2458-4FFC-A409-38E42EAA4EC6Q38778176-84148507-C7E8-461B-AB75-9DCD05226C0FQ38845150-180AD8FD-F5E4-4B8F-8C9F-897D902005FBQ38854056-1C354BAE-8A1C-4AD3-A472-E91E26BF9258Q38895164-48EF832B-DF37-48D9-A0FB-4A4C5F68A59CQ40917993-39C9AAF6-C18E-4D3C-A1F6-D34400BF9E1FQ41390229-793A37C6-CCFD-477F-83A4-68F74FDA60C5Q41709162-09A81F90-6F0B-4011-82FB-6AD74FA7B05DQ42180884-689A8A68-4C1B-46E6-8CD3-D14560D3B474Q42206952-8ABB7AF6-D652-4DA8-A3B0-009D7E753352Q47099877-20E85707-7A7E-401D-8244-C0F6596BEC22Q47143181-5D4C6A48-BBDC-46CE-B8A8-4C013C34697FQ47395337-594894B9-ABF5-4EAC-A90A-0C314CDB3CC2Q53237335-3B365371-C242-4FD9-9934-AD31C6C59CFDQ53285566-80AA73F2-9681-4AB1-A414-74DF4A00C59B
P2860
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)
@ast
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)
@en
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma
@nl
type
label
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)
@ast
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)
@en
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma
@nl
prefLabel
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)
@ast
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)
@en
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma
@nl
P2093
P2860
P356
P1433
P1476
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)
@en
P2093
Hiroyuki Shinchi
Kiyokazu Hiwatashi
Koji Minami
Kosei Maemura
Masahiko Sakoda
Motoyuki Hashiguchi
Satoshi Iino
Shinichi Ueno
Shoji Natsugoe
P2860
P2888
P356
10.1186/1471-2407-13-572
P407
P577
2013-12-05T00:00:00Z
P5875
P6179
1051079933